基于结构的识别Jervine作为细胞循环激酶的强有力的双重向抑制剂
Md Nayab Sulaimani1, Khadija Imtiyaz2, Md Imtaiyaz Hassan1
1Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, India.
Frontiers in pharmacology
|December 8, 2025
概括
这项研究确定了Jervine作为AURKB和CDK1的强有力的双向抑制剂,在癌症中具有关键的细胞循环激酶. 计算分析证实了其强大的结合亲和力和有利的类似药物的特性,有利于潜在的抗癌药物开发.
科学领域:
- 生物化学和分子生物学
- 计算化学计算化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞周期调节剂,如极光激酶B (AURKB) 和循环素依赖激酶1 (CDK1),对于基因组的稳定性至关重要.
- 对AURKB和CDK1的失调与癌症特征有关,例如动脉积分和不受控制的增殖.
- 准这些激酶为癌症治疗提供了一个有希望的策略,潜在的副作用更少.
研究的目的:
- 使用计算方法发现AURKB和CDK1的新型双向抑制剂.
- 从印度药用植物,植物化学和治疗 (IMPPAT) 数据库中识别潜在的抗癌化合物.
- 评估已识别的抑制剂的结合亲和力,稳定性和类似药物的特性.
主要方法:
- 从IMPPAT数据库中对植物化学品进行高通量虚拟选.
- 识别针对AURKB和CDK1的常见化合物.
- 分子对接,分子动力学 (MD) 模拟 (300 ns) 和分子力学与Poisson-Boltzmann表面积 (MMPBSA) 分析.
- 评估药物相似性和药物动力学特性.
主要成果:
- 杰尔文是一种类固醇类化合物,被确定为一种强大的双向抑制剂,具有高结合亲和力和对AURKB和CDK1.1的配体效率.
- MD模拟证实了Jervine与两种激酶的稳定相互作用和结构完整性.
- 与VX-680与AURKB相比,MMPBSA分析显示Jervine的结合自由能量更高.
- 杰维因表现出有利的类似药物和药理动力学特性.
结论:
- 杰尔文是一种有前途的双向激酶抑制剂,用于AURKB和CDK1.
- 该化合物表现出强大的抗癌潜力,由于其强大的结合亲和力和有利的特性.
- 进一步的实验验证是为Jervine作为抗癌治疗药物的发展提供了保证.
相关概念视频
02:34Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
02:11The Cell Cycle Control System
13.9K
The cell cycle is an organized set of events that leads the cell to divide into two daughter cells, each containing chromosomes identical to the parent cell. It is the cell cycle that leads to the formation of an entire organism from a single-cell zygote. Besides, cell division also functions in the renewal or repair of tissues in adult multicellular eukaryotes. For example, in the bone marrow, the stem cells divide to form new blood cells. Although essential for several functions, cell...
13.9K
01:28The Cell Cycle Control System
5.2K
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...
5.2K
02:54Protein Kinases and Phosphatases
4.3K
4.3K
02:54Protein Kinases and Phosphatases
14.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.9K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K